Drug Trial Radar · NCT03679884
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Last checked: Nov 19, 2026Latest source record: Mar 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
804
Actual
Start
Oct 9, 2018
Primary completion
Feb 22, 2021
Study completion Feb 22, 2021
Sponsor
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 21, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study to assess the long term safety and tolerability of daridorexant in adult and elderly subjects suffering from difficulties to sleep
Conditions
- Insomnia Disorder
Interventions
Daridorexant 10 mgDrug
Daridorexant 10 mg film-coated tablets
Daridorexant 25 mgDrug
Daridorexant 25 mg film-coated tablets
Daridorexant 50 mgDrug
Daridorexant 50 mg film-coated tablets
PlaceboDrug
Matching placebo film-coated tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total no. of Subjects With at Least One TEAETime frame: TEAEs (AEs that started or worsened during the double-blind study period up to 30 days after double-blind study treatment end date) are reported. Total duration: up to 44 weeks.
Locations
106 sites in 14 countries. Site status is shown where the registry gives one.
Pulmonary Associates of the Southeast/WCR
Birmingham, Alabama
Pulmonary Associates, Pa
Glendale, Arizona
Noble Clinical Research
Tucson, Arizona
Preferred Research Partners, Inc
Little Rock, Arkansas
Woodland International Research Group
Little Rock, Arkansas
Core Healthcare Group
Cerritos, California
Marvel Clinical Research
Huntington Beach, California
Clinical Trials Research
Lincoln, California
Long Beach Clinical Trials
Long Beach, California
Artemis Institute For Clinical Research - Riverside
Riverside, California
Artemis institute for Clinical Research
San Diego, California
Pacific Research Network
San Diego, California
Artemis Institute for Clinical Research
San Marcos, California
Santa Monica Clinical Trials
Santa Monica, California
Empire Clinical Research
Upland, California
Innovative Clinical Research
Lafayette, Colorado
PAB Clinical Research
Brandon, Florida
St. Francis Sleep Allergy and Lung Institute
Clearwater, Florida
Clinical Research of South Florida
Coral Gables, Florida
Fleming Island Center for Clinical Research
Fleming Island, Florida
Research Centers of America
Hollywood, Florida
Canvas Clinical Research, LLC
Lake Worth, Florida
BioMed Research Institute
Miami, Florida
Clinical Research Group of St. Petersburgh
St. Petersburg, Florida
Clinical Site Partners, LLC
Winter Park, Florida
Neurotrials Research Incorporated
Atlanta, Georgia
Sleep Practitioners, LLC
Macon, Georgia
Saltzer Clinical Research
Nampa, Idaho
Helene Emsellem, MD
Chevy Chase, Maryland
Sleep Disorders Center of the Mid-Atlantic
Glen Burnie, Maryland
Infinity Medical Research, Inc.
North Dartmouth, Massachusetts
Precise Research Centers
Flowood, Mississippi
Barrett Clinic
La Vista, Nebraska
Clinical Research Center of Nevada
Las Vegas, Nevada
Clinilabs NYC
New York, New York
Research Carolina of Hickory
Hickory, North Carolina
Research Carolina of Huntersville
Huntersville, North Carolina
Coastal Carolina Healthcare
New Bern, North Carolina
Wake Research Associates
Raleigh, North Carolina
Clinical Trials of America - NC, LLC
Winston-Salem, North Carolina
Showing 40 of 106 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.